MBrace Therapeutics
San Diego, United States · $110.0M raised
- Headquarters
- San Diego, California
- Business Model
- B2B
- Website
- mbracetrx.com
- Total Funding
- $110.0M
- Last Round
- $25.0M Series ANov 2023
- Rounds
- 2
About
Clinical-stage biopharmaceutical company developing antibody-drug conjugates targeting novel oncology proteins.
Summary
MBrace Therapeutics is a Biotech company based in San Diego, United States. It has raised $110.0M in total across 2 rounds, most recently a $25.0M Series A round in Nov 2023. Investors include Venrock, TPG Life Sciences Innovations and Advanced Technology Ventures.
Tech & App Stack
3 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Nov 2023
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...